Articles published by Noetik

GSK Licenses Noetik’s AI Foundation Models in Anchor Partnership to Transform Cancer Therapeutic Research and Development

January 08, 2026

From Noetik

Via Business Wire

Noetik Expands Scientific Advisory Board to Build the Future of Cancer Therapeutics

October 01, 2025

From Noetik

Via Business Wire

Noetik Names Dr. Emily Corse Executive Vice President of Therapeutics to Accelerate AI-Powered Therapeutics Pipeline

April 10, 2025

From Noetik

Via Business Wire

Noetik Announces OCTO-VirtualCell and Celleporter: Foundation Models of Spatial Biology for Precision Oncology

December 18, 2024

From Noetik

Via Business Wire

Noetik Announces First-in-Class Human Foundation Models for Discovery at SITC 2024

November 07, 2024

From Noetik

Via Business Wire

Noetik Selected to Participate in the 2024 AWS Generative AI Accelerator

September 12, 2024

From Noetik

Via Business Wire

Noetik Secures $40 Million Series A Financing to Advance Precision Cancer Therapies

August 29, 2024

From Noetik

Via Business Wire

Noetik Appoints Dr. Shafique Virani as Chief Business Officer

March 27, 2024

From Noetik

Via Business Wire

Noetik Launches "Perturb-map" In Vivo Functional Genomics Platform and Adds Precision Immunology Leader Brian Brown, Ph.D. to Scientific Advisory Board

November 15, 2023

From Noetik

Via Business Wire

Noetik Raises $14 Million Seed Financing to Revolutionize Cancer Immunotherapy Using Artificial Intelligence

September 07, 2023

From Noetik

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.